Vyome Achieves Quoted Status via Backdoor Listing
21 Aug 2025
US$ 20.00
US-based Vyome Therapeutics Inc, a clinical-stage pharmaceutical company backed by investors including Kalaari Capital...
Related Publications
Subscribers’ Weekly for the week ending 22 Aug 2025...
Listen to Australia/New Zealand Divestments (Subscribers' Weekly 22 Aug 2025)...
Connect With Us
We love to share Asia PE insights and news from time to time. Drop us your email address if you like to hear from us.
Rest assured that your email address will not be shared, as we hate spams as much as you do.